|
Titan Biotech Ltd.
|
Income Statement
|
|
|
You can view the
Income Statement
for the last 5 years.
|
Market Cap. (Rs.)
|
809.84 Cr.
|
P/BV
|
5.28
|
Book Value (Rs.)
|
185.64
|
|
52 Week High/Low (Rs.)
|
1419/374
|
FV/ML
|
10/1
|
P/E(X)
|
37.61
|
|
Bookclosure
|
19/09/2025
|
EPS (Rs.)
|
26.06
|
Div Yield (%)
|
0.20
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| | | | | | |
| INCOME | | | | | |
| Revenue From Operations [Net] | 156.45 | 164.07 | 144.00 | 152.81 | 142.24 |
| Total Operating Revenues | 156.45 | 164.07 | 144.00 | 152.81 | 142.24 |
| | | | | | |
| Other Income | 3.91 | 1.75 | 1.94 | 1.02 | 0.79 |
| Total Revenue | 160.36 | 165.82 | 145.94 | 153.83 | 143.03 |
| | | | | | |
| EXPENSES | | | | | |
| Cost Of Materials Consumed | 75.48 | 80.89 | 70.81 | 75.48 | 67.30 |
| Operating And Direct Expenses | 16.62 | 18.13 | 15.77 | 12.24 | 10.72 |
| Changes In Inventories Of FG,WIP And Stock-In Trade | -2.85 | -5.29 | -0.93 | -0.60 | -2.73 |
| Employee Benefit Expenses | 26.38 | 23.71 | 18.21 | 16.14 | 14.05 |
| Finance Costs | 0.80 | 1.17 | 0.75 | 1.28 | 1.67 |
| Depreciation And Amortisation Expenses | 4.17 | 3.33 | 2.60 | 2.54 | 2.22 |
| Other Expenses | 15.39 | 12.34 | 10.63 | 8.56 | 6.77 |
| Total Expenses | 136.00 | 134.29 | 117.83 | 115.63 | 100.00 |
| | | | | | |
| Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 24.37 | 31.53 | 28.12 | 38.20 | 43.03 |
| | | | | | |
| Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | -0.32 |
| Profit/Loss Before Tax | 24.37 | 31.53 | 28.12 | 38.20 | 42.71 |
| | | | | | |
| Tax Expenses-Continued Operations | | | | | |
| Current Tax | 5.97 | 7.79 | 7.21 | 9.70 | 10.86 |
| Deferred Tax | 0.12 | 0.11 | -0.09 | -0.07 | 0.14 |
| Tax For Earlier Years | 0.00 | -0.03 | -0.03 | 0.02 | 0.01 |
| Total Tax Expenses | 6.10 | 7.87 | 7.09 | 9.65 | 11.00 |
| Profit/Loss After Tax And Before ExtraOrdinary Items | 18.27 | 23.66 | 21.02 | 28.55 | 31.71 |
| | | | | | |
| Profit/Loss From Continuing Operations | 18.27 | 23.66 | 21.02 | 28.55 | 31.71 |
| | | | | | |
| Profit/Loss For The Period | 18.27 | 23.66 | 21.02 | 28.55 | 31.71 |
| | | | | | |
| Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | -1.37 |
| Share Of Profit/Loss Of Associates | 3.26 | 1.19 | 3.82 | 0.19 | 0.00 |
| Consolidated Profit/Loss After MI And Associates | 21.53 | 24.85 | 24.84 | 28.74 | 30.34 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| EARNINGS PER SHARE | | | | | |
| Basic EPS (Rs.) | 26.06 | 30.07 | 25.44 | 30.66 | 36.71 |
| Diluted EPS (Rs.) | 26.06 | 30.07 | 25.44 | 30.66 | 36.71 |
| | | | | | |
| DIVIDEND AND DIVIDEND PERCENTAGE | | | | | |
| Equity Share Dividend | 1.65 | 1.49 | 1.24 | 1.24 | 0.83 |
